Cargando…
Practice guidelines for BRCA1/2 tumour testing in ovarian cancer
The purpose of this document is to provide pre-analytical, analytical and post-analytical considerations and recommendations to Canadian clinical laboratories developing, validating and offering next-generation sequencing (NGS)-based BRCA1 and BRCA2 (BRCA1/2) tumour testing in ovarian cancers. This...
Autores principales: | Grafodatskaya, Daria, O’Rielly, Darren D, Bedard, Karine, Butcher, Darci T, Howlett, Christopher J, Lytwyn, Alice, McCready, Elizabeth, Parboosingh, Jillian, Spriggs, Elizabeth L, Vaags, Andrea K, Stockley, Tracy L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340048/ https://www.ncbi.nlm.nih.gov/pubmed/35393334 http://dx.doi.org/10.1136/jmedgenet-2021-108238 |
Ejemplares similares
-
CCMG practice guideline: laboratory guidelines for next-generation sequencing
por: Hume, Stacey, et al.
Publicado: (2019) -
A Pan-Canadian Validation Study for the Detection of EGFR T790M Mutation Using Circulating Tumor DNA From Peripheral Blood
por: Selvarajah, Shamini, et al.
Publicado: (2021) -
Evaluation of DNA Methylation Array for Glioma Tumor Profiling and Description of a Novel Epi-Signature to Distinguish IDH1/IDH2 Mutant and Wild-Type Tumors
por: Schenkel, Laila C., et al.
Publicado: (2022) -
Pharmacogenetics of rheumatoid arthritis: Potential targets from susceptibility genes and present therapies
por: O’Rielly, Darren D, et al.
Publicado: (2010) -
The effect of age and perturbation time on online control during rapid pointing
por: O’Rielly, Jessica L., et al.
Publicado: (2019)